PT1009419E - Processo para identificar alergenios dos polens das gramineas recombinantes modificados - Google Patents

Processo para identificar alergenios dos polens das gramineas recombinantes modificados

Info

Publication number
PT1009419E
PT1009419E PT98914887T PT98914887T PT1009419E PT 1009419 E PT1009419 E PT 1009419E PT 98914887 T PT98914887 T PT 98914887T PT 98914887 T PT98914887 T PT 98914887T PT 1009419 E PT1009419 E PT 1009419E
Authority
PT
Portugal
Prior art keywords
modified recombinant
graminees
allergenes
allergens
specific
Prior art date
Application number
PT98914887T
Other languages
English (en)
Inventor
Kahlert Helga
Stuewe Hans-Thomas
Fiebig Helmut
Cromwell Oliver
Becker Wolf-Meinhard
Bufe Albrecht Prof Dr Med
Schramm Gabriele
Jaeger Lothar
Mueller Wolf-Dieter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT1009419E publication Critical patent/PT1009419E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT98914887T 1997-03-27 1998-03-16 Processo para identificar alergenios dos polens das gramineas recombinantes modificados PT1009419E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19713001A DE19713001A1 (de) 1997-03-27 1997-03-27 Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
PT1009419E true PT1009419E (pt) 2006-10-31

Family

ID=7824864

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98914887T PT1009419E (pt) 1997-03-27 1998-03-16 Processo para identificar alergenios dos polens das gramineas recombinantes modificados

Country Status (10)

Country Link
US (1) US6919086B1 (pt)
EP (1) EP1009419B1 (pt)
JP (2) JP4347418B2 (pt)
AT (1) ATE327252T1 (pt)
DE (2) DE19713001A1 (pt)
ES (1) ES2264201T3 (pt)
HU (1) HUP0001552A2 (pt)
PL (1) PL196830B1 (pt)
PT (1) PT1009419E (pt)
WO (1) WO1998043657A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19713001A1 (de) * 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
WO2000052154A2 (en) * 1999-03-02 2000-09-08 The Board Of Trustees Of The University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
SE9903950D0 (sv) * 1999-10-29 1999-10-29 Pharmacia & Upjohn Diag Ab Non-anaphylactic forms of grass pollen allergen and their use
US6572859B1 (en) 1999-10-29 2003-06-03 Pharmacia Diagnostics Ab Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
JP2004521618A (ja) * 2000-11-16 2004-07-22 アルカベロ アクチェセルスカプ 新規変異体アレルゲン
AUPR779201A0 (en) * 2001-09-20 2001-10-11 University Of Melbourne, The Immunotherapeutic and immunoprophylactic reagents
SE0200946D0 (sv) * 2002-03-27 2002-03-27 Pharmacia Diagnostics Ab Novel Allergen
EP1356826A1 (en) * 2002-04-22 2003-10-29 BIOMAY Produktions- und Handels- Aktiengesellschaft Microparticles comprising carbohydrate beads covalently linked with allergen
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
PL2287180T3 (pl) * 2003-06-04 2013-12-31 Merck Patent Gmbh Pochodne Lol p 5 o zredukowanej alergeniczności i utrzymanej reaktywności dla komórek T
CN102811735B (zh) * 2010-01-14 2015-09-09 默克专利股份公司 由于脯氨酸残基突变而具有降低的致敏性的禾本科的第6组过敏原的变异体
EP2523685A1 (de) * 2010-01-14 2012-11-21 Merck Patent GmbH VARIANTEN DER GRUPPE 5-ALLERGENE DER SÜßGRÄSER MIT REDUZIERTER ALLERGENITÄT DURCH MUTAGENESE VON PROLINRESTEN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174822T3 (es) * 1989-11-03 2002-11-16 Immulogic Pharma Corp Una proteina felina reactiva con celulas t humanas (trfp) aislada de polvo domestico y usos para la misma.
WO1994004564A1 (en) 1992-08-14 1994-03-03 The University Of Melbourne T cell epitopes of ryegrass pollen allergen
DE19713001A1 (de) * 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
HUP0001552A2 (hu) 2000-09-28
JP2009062368A (ja) 2009-03-26
WO1998043657A2 (de) 1998-10-08
EP1009419B1 (de) 2006-05-24
US6919086B1 (en) 2005-07-19
ES2264201T3 (es) 2006-12-16
ATE327252T1 (de) 2006-06-15
PL335981A1 (en) 2000-06-05
EP1009419A2 (de) 2000-06-21
PL196830B1 (pl) 2008-02-29
JP5290671B2 (ja) 2013-09-18
DE59813556D1 (de) 2006-06-29
JP4347418B2 (ja) 2009-10-21
JP2002511842A (ja) 2002-04-16
DE19713001A1 (de) 1998-10-01
WO1998043657A3 (de) 1999-01-21

Similar Documents

Publication Publication Date Title
PT1009419E (pt) Processo para identificar alergenios dos polens das gramineas recombinantes modificados
Ramesh et al. Peanut T-cell epitope discovery: Ara h 1
DE69020143D1 (de) Verfahren zur verwendung und herstellung von peptiden.
CN101115504A (zh) 控制次要过敏原以便提高免疫疗法的安全性
ATE177756T1 (de) Neue peptide aus einem autoantigen zur verwendung bei immuntherapie von autoimmunkrankheit
DE69433243D1 (de) Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit
ATE175209T1 (de) Allergene proteine aus ambrosia und verwendung davon
Elsayed et al. T cell recognition pattern of bovine milk αS1-casein and its peptides
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
CA2270877A1 (en) Peptide-based immunotherapeutic agent
EP2028189A3 (de) Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität
CA2381340C (en) Method for isolating and purifying grass pollen allergens
Schou Allergens in rhinitis. B-and T-cell epitopes of allergen molecules.
EP0707065A3 (en) Parietaria allergens
ATE185151T1 (de) Neue peptide zur verwendung bei behandlung von durch t-zellen vermittelter knorpelzerstörungin autoimmunkrankheiten
ATE432080T1 (de) Lo-cd2a antikörper und deren verwendung zur hemmung der t-zellen aktivierung und proliferation
Paull et al. Separation of active subunits of ragweed antigen E
ATE302213T1 (de) Nicht-anaphylaktische formen des grasspollenallergens ph1 p 6 und deren verwendung
ATE407148T1 (de) Gruppe-2-allergen-spezifische igg-moleküle und deren verwendung
Lind et al. 403 Characterization of cockroach extracts and purification of a cross-reacting, acidic allergen
WO2001040266A3 (de) INSEKTENGIFT-ALLERGENE MIT VERMINDERTER IgE-REAKTIVITÄT UND VERFAHREN ZU IHRER HERSTELLUNG
O'Neil et al. 405 Partial purfication and allergenic characterization of imported fire ant (IFA) whole body extract (IFAWBE)
Lemke et al. 406 Allergy to ethylene oxide (ETO) and to muscle relaxants is mediated by cross-reacting IgE against quarternary ammonium ion determinants
Fernández-Caldas et al. Immunochemical characterization of antigenic fragments of Olea europaea and Phleum pratense
Helm et al. 404 Cross-reactivity of cockroach (CR) allergens: Rast inhibition and immunoblot analysis of Asian cockroach (ACR)(Blattella asahinai) and German cockroach (GCR)(Blattella germanica) extracts